Adamas settles Gocovri clash with Sandoz
Natee Meepian / iStockphoto.com
AbbVie has announced yet another settlement relating to litigation over Humira (adalimumab), a drug used to treat multiple types of arthritis as well as psoriasis.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
AbbVie, Humira, Sandoz, licence agreement, patent, patent agreement, Amgen, generics, biopharmaceuticals